Ceranib-2

• CAT Number: I011546
• CAS Number: 1402830-75-4
• Molecular Formula: C24H17NO3
• Molecular Weight: 367.404
• Purity: ≥95%
• Target: Ceramidases
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: 3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-phenyl-1H-quinolin-2-one
• InChI: InChI=1S/C24H17NO3/c26-18-13-10-16(11-14-18)12-15-21(27)23-22(17-6-2-1-3-7-17)19-8-4-5-9-20(19)25-24(23)28/h1-15,26H,(H,25,28)/b15-12+
• InChIKey: QUJIMYXGRCETPJ-NTCAYCPXSA-N
• SMILES: C1=CC=C(C=C1)C2=C(C(=O)NC3=CC=CC=C32)C(=O)C=CC4=CC=C(C=C4)O

Ceranib-2 (CAT: I011546) is indeed a small molecule inhibitor that targets the lipoprotein lipase (LPL) receptor, which is involved in the metabolism of lipids and plays a key role in the regulation of lipid levels in the blood. By inhibiting the activity of the LPL receptor, Ceranib-2 has been shown to reduce the uptake of lipids in adipose tissue and the liver, leading to a decrease in circulating lipid levels. Ceranib-2 has been studied for its potential therapeutic applications in the treatment of various metabolic disorders, such as dyslipidemia and insulin resistance, and has shown promising results in preclinical studies.